Chinese expert consensus on the diagnosis and treatment of IgG4 related diseases
IgG4 related disease (IgG4-RD) is an immune medicated rare disease, characterized with chronic inflammation and fibrosis in the involved organs, it is a systemic disease affected nearly every anatomic site of the body, usually involvement of multiple organs, and with diverse clinical manifestations. Due to the the relative novelty of the disease and under-recognition, the overall level of diagnosis and treatment in China is uneven. Till now, there is no relevant expert consensus or guidance of IgG4-RD in China. In order to further improve the understanding and standardize the management of IgG4-RD, on the basis of summarizing domestic and international experience, the China Alliance For Rare Diseases, together with the Chinese Rheumatology Association, organized an expert group and established the Chinese expert consensus on the diagnosis and treatment of IgG4 related diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Zhonghua nei ke za zhi - 60(2021), 3 vom: 01. März, Seite 192-206 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
Zhang, W [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.03.2021 Date Revised 08.03.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3760/cma.j.cn112138-20200803-00726 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322205573 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322205573 | ||
| 003 | DE-627 | ||
| 005 | 20231225181535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3760/cma.j.cn112138-20200803-00726 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1073.xml |
| 035 | |a (DE-627)NLM322205573 | ||
| 035 | |a (NLM)33663167 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 1 | |a Zhang, W |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chinese expert consensus on the diagnosis and treatment of IgG4 related diseases |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.03.2021 | ||
| 500 | |a Date Revised 08.03.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a IgG4 related disease (IgG4-RD) is an immune medicated rare disease, characterized with chronic inflammation and fibrosis in the involved organs, it is a systemic disease affected nearly every anatomic site of the body, usually involvement of multiple organs, and with diverse clinical manifestations. Due to the the relative novelty of the disease and under-recognition, the overall level of diagnosis and treatment in China is uneven. Till now, there is no relevant expert consensus or guidance of IgG4-RD in China. In order to further improve the understanding and standardize the management of IgG4-RD, on the basis of summarizing domestic and international experience, the China Alliance For Rare Diseases, together with the Chinese Rheumatology Association, organized an expert group and established the Chinese expert consensus on the diagnosis and treatment of IgG4 related diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 700 | 1 | |a Dong, L L |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, J |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Y Y |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, X F |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, S Y |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhonghua nei ke za zhi |d 1957 |g 60(2021), 3 vom: 01. März, Seite 192-206 |w (DE-627)NLM000465526 |x 0578-1426 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:3 |g day:01 |g month:03 |g pages:192-206 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112138-20200803-00726 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 3 |b 01 |c 03 |h 192-206 | ||